Free Trial

Genesco (NYSE:GCO) Announces Earnings Results, Beats Expectations By $0.31 EPS

Genesco logo with Retail/Wholesale background

Genesco (NYSE:GCO - Get Free Report) released its quarterly earnings results on Friday. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.30 by $0.31, Zacks reports. The business had revenue of $596.30 million during the quarter, compared to analyst estimates of $577.73 million. Genesco had a negative net margin of 0.03% and a positive return on equity of 0.49%. The company's quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.57 earnings per share. Genesco updated its FY 2025 guidance to 0.800-1.000 EPS and its FY25 guidance to $0.80-1.00 EPS.

Genesco Stock Up 9.5 %

NYSE GCO traded up $3.54 during trading on Friday, hitting $40.95. The company's stock had a trading volume of 362,542 shares, compared to its average volume of 136,801. Genesco has a fifty-two week low of $23.21 and a fifty-two week high of $43.00. The company has a market cap of $459.54 million, a PE ratio of -16.85 and a beta of 2.47. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.53 and a quick ratio of 0.40. The business's 50 day simple moving average is $29.80 and its 200-day simple moving average is $28.11.

Analyst Ratings Changes

Separately, StockNews.com raised Genesco from a "hold" rating to a "buy" rating in a research report on Friday.

View Our Latest Research Report on Genesco

About Genesco

(Get Free Report)

Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.

Further Reading

Earnings History for Genesco (NYSE:GCO)

Should you invest $1,000 in Genesco right now?

Before you consider Genesco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.

While Genesco currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Energy Stocks Are Poised for Explosive Growth in 2025
From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines